2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative

…, RP Naden, TA Medsger Jr, PE Carreira… - Arthritis & …, 2013 - Wiley Online Library
Objective The 1980 American College of Rheumatology (ACR) classification criteria for
systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present …

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

…, M Vonk, P Airò, F Cozzi, PE Carreira… - Annals of the …, 2010 - ard.bmj.com
Objectives To determine the causes and predictors of mortality in systemic sclerosis (SSc).
Methods Patients with SSc (n=5860) fulfilling the American College of Rheumatology criteria …

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative

…, RP Naden, TA Medsger, PE Carreira… - 2013 - deepblue.lib.umich.edu
Objective. The 1980 American College of Rheuma-tology (ACR) classification criteria for
systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present …

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

…, FJL Longo, CS Aznar, P Carreira… - The Lancet …, 2020 - thelancet.com
Background A phase 2 trial of tocilizumab showed preliminary evidence of efficacy in systemic
sclerosis. We assessed skin fibrosis and systemic sclerosis-associated interstitial lung …

Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

…, R Scorza, BA Lie, AM Hoffmann-Vold, P Carreira… - Nature …, 2010 - nature.com
Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis of the skin and
internal organs that leads to profound disability and premature death. To identify new SSc …

[HTML][HTML] Overexpression of the cytokine BAFF and autoimmunity risk

…, L Alfredsson, A Suarez, PE Carreira… - … England Journal of …, 2017 - Mass Medical Soc
Background Genomewide association studies of autoimmune diseases have mapped hundreds
of susceptibility regions in the genome. However, only for a few association signals has …

[PDF][PDF] Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis

…, AT Lee, E López-Isac, E Ochoa, P Carreira… - The American Journal of …, 2014 - cell.com
In this study, 1,833 systemic sclerosis (SSc) cases and 3,466 controls were genotyped with
the Immunochip array. Classical alleles, amino acid residues, and SNPs across the human …

The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements

…, S Barsotti, C Bruni, P Carducci, PE Carreira… - The Lancet …, 2020 - thelancet.com
Background Systemic sclerosis-associated interstitial lung disease (ILD) carries a high
mortality risk; expert guidance is required to aid early recognition and treatment. We aimed to …

[HTML][HTML] A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients …

…, G Pekovic, M Radovic, G Radunovic, P Carreira… - Kidney international, 2019 - Elsevier
Calcineurin inhibitors added to standard-of-care induction therapy for lupus nephritis (LN)
may increase complete renal remission (CRR) rates. The AURA-LV study tested the novel …

[HTML][HTML] Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy

…, Ø Palm, P Garcia de la Pena, P Carreira… - PLoS …, 2011 - journals.plos.org
The aim of this study was to determine, through a genome-wide association study (GWAS),
the genetic components contributing to different clinical sub-phenotypes of systemic sclerosis …